Abstract
How respiratory physiology and airflow therein proceed to impact SARS-CoV-2 transmission, leading to the initial infection, is an open question. An answer can help determine the susceptibility of an individual on exposure to a COVID-2019 carrier and can also quantify the still-unknown infectious dose for the disease. Combining computational fluid mechanics-based tracking of respiratory transport in anatomic domains with sputum assessment data from hospitalized patients and earlier measurements of ejecta size distribution during regular speech – this study shows that targeted deposition at the initial nasopharyngeal infection sites peaks over the droplet size range of 2.5 – 19 µ, and reveals that the number of virions that can establish the infection is at most of 𝒪 (102).
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This material is based upon work supported by the National Science Foundation (NSF), under Award Number 2028069 for COVID-19 research. Any opinions, findings, and conclusions or recommendations expressed here are those of the author and do not necessarily reflect NSF's views. Supplemental support came from SB's faculty start-up package at SDSU.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Institutional Review Board at the University of North Carolina at Chapel Hill
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* saikat.basu{at}sdstate.edu / saikat_basu{at}med.unc.edu
Data Availability
This project has generated simulated quantitative, de-identified data on regional deposition along nasal tissues. The data-sets (including Fluent .cas, .dat files) and the numeric protocols; along with MATLAB codes, Wolfram Mathematica notebooks, and Microsoft Excel spreadsheets used for data post-processing - are available from the corresponding author on request, through a shared-domain Google Drive folder (see the reference list).
https://drive.google.com/drive/folders/1OnEo_fPtSzIqG5_VLKpsg3L5ixG108cI?usp=sharing
